Chromadex, The Potential "Game Changer" In Patient Dependency Of The Multi-Billion Dollar Pharmaceutical Industry
CHICAGO, Nov. 8, 2012 /PRNewswire/ - Imagine a world where organic vitamins and dietary supplements prevented the use of engineered medication. Where patients could naturally treat medical problems without adhering to the many various side effects of pharmaceutical drugs. This is a notion that could appeal to the millions of Americans dealing with the defects of routine prescription drug consumption.
Natural compounds such as pterostilbene and resveratrol have been tested to assist in treating ailing conditions such as high blood pressure and high cholesterol. Chromadex is a natural product company that examines these organic compounds in order to discover any medical use for them. Once they do, they create a patent on how to manufacture the compound with obtaining the rights of both the health claims and the patent itself. These ingredients are sold under the dietary supplement category through retail and other traditional marketing outlets.
The 13-year old company has already tested thousands of products, creating over a dozen patents marketed across the world. Its most recent branded patent, pTeroPure derives from pterostilbene, an organic antioxidant compound found in blueberries. So far, pTeroPure has shown breakthrough potential for Chromadex. A clinical study conducted by the University of Mississippi Medical Center indicates that its primary ingredient, pterostilbene significantly reduces blood pressure in adults, without posing any side effects.
University of Mississippi Medical Center PharmD Cardiometabolic Clinic Coordinator Dr. Daniel Riche reported that the 8 week study of the organic compound presented no significant safety concerns from the 80 people tested in the trial. In addition to safety, the study tested the effects of high blood pressure and cholesterol. Although the results on cholesterol were neutral, Riche mentioned that its effect on the 55 percent of subjects suffering from high blood pressure, displayed mercury point reductions by up to 7 percent."We put it into patients who would be considered to have elevated cholesterol levels and and regular blood pressure levels. Although we did not put it with patients with elevated blood pressure, it still reduced blood pressure. So of course the next step is to put it into patients who have elevated blood pressure on multiple medications," said Riche.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts